Serum IL-17 and IL-23 levels can distinguish between severe and non-severe inflammatory bowel disease

被引：0
|
作者：
Lucaciu, L. [1 ,2 ]
Ilies, M. [3 ]
Iuga, C. [3 ,4 ]
Seicean, A. [1 ,2 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Gastroenterol & Hepatol, Cluj Napoca, Romania
[2] Reg Inst Gastroenterol & Hepatol, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Anal, Fac Pharm, Cluj Napoca, Romania
[4] MedFuture Res Ctr Adv Med, Dept Prote & Metabol, Cluj Napoca, Romania
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P136
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [1] Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
    Lucaciu, Laura A.
    Ilies, Maria
    Vesa, Stefan C.
    Seicean, Radu
    Din, Shahida
    Iuga, Cristina Adela
    Seicean, Andrada
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [2] The IL-23/IL-17 pathway in inflammatory bowel disease
    Geremia, Alessandra
    Jewell, Derek P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (02) : 223 - 237
  • [3] Differential roles for IL-23 and IL-17 in inflammatory bowel disease
    Towne, J. E.
    Maxwell, J. R.
    Zhang, Y.
    Brown, W. A.
    Rottman, J. B.
    Budelsky, A. L.
    CYTOKINE, 2012, 59 (03) : 515 - 515
  • [4] Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
    Catana, Cristina-Sorina
    Neagoe, Ioana Berindan
    Cozma, Vasile
    Magdas, Cristian
    Tabaran, Flaviu
    Dumitrascu, Dan Lucian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5823 - 5830
  • [5] THE ROLE OF IL-17, IL-23 SERUM LEVELS IN PATIENTS WITH ANKYLOSING SPONDYLITIS WITH INFLAMMATORY BOWEL DISEASES
    Lukina, G.
    Kulakova, P.
    Alexandrova, E.
    Novikov, A.
    Savenkova, N.
    Klimets, A.
    Kartushina, I.
    Kovshik, A.
    Volnukhin, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1551 - 1551
  • [6] Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
    Cristina-Sorina Cǎanǎ
    Ioana Berindan Neagoe
    Vasile Cozma
    Cristian Magdas
    Flaviu Tǎbǎan
    Dan Lucian Dumitrasu
    World Journal of Gastroenterology, 2015, (19) : 5823 - 5830
  • [7] Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease
    Verstockt, Bram
    Van Assche, Gert
    Vermeire, Severine
    Ferrante, Marc
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (01) : 31 - 47
  • [8] THE ADMINISTRATION OF TRICHURIS SUIS OVA EXTRACT DECREASES IL-17/IL-23 LEVELS IN EXPERIMENTAL INFLAMMATORY BOWEL DISEASE
    Catana, Cristina-Sorina
    Magdas, Cristian
    Budisan, Liviuta
    Craciun, Elena-Cristina
    Tabaran, Flaviu
    Deak, Georgiana
    Magdas, Virginia Ana
    Pestean, Cosmin
    Ober, Ciprian
    Berindan-Neagoe, Ioana
    Cozma, Vasile
    Cozma-Petrut, Anamaria
    Dumitrascu, Dan Lucian
    FARMACIA, 2018, 66 (06) : 1021 - 1027
  • [9] The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 415 - 429
  • [10] Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis
    Bilik, Mehmet Zihni
    Kaplan, Ibrahim
    Polat, Nihat
    Akil, Mehmet Ata
    Akyuz, Abdurrahman
    Acet, Halit
    Yuksel, Murat
    Inci, Umit
    Kayan, Fethullah
    Toprak, Nizamettin
    MEDICINE, 2016, 95 (18) : e3562
12345